Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

INTRODUCTION: Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha (PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties. Fenofibrate is effective against a variety of viral infections and different inflammatory disorders. Therefore, the aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhayyat, Shadi Salem, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., El-Bouseary, Maisra M., AboKamer, Amal M., Batiha, Gaber El-Saber, Simal-Gandara, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360649/
https://www.ncbi.nlm.nih.gov/pubmed/35941297
http://dx.doi.org/10.1007/s00011-022-01615-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360649/
https://www.ncbi.nlm.nih.gov/pubmed/35941297
http://dx.doi.org/10.1007/s00011-022-01615-w

Ejemplares similares